| Literature DB >> 34418324 |
Caroliene M Meijndert1, Gerry M Raghoebar1, Arjan Vissink1, Konstantina Delli1, Henny J A Meijer1,2.
Abstract
OBJECTIVE: To systematically review literature about the effect of different implant-abutment interface designs on peri-implant bone level changes, implant loss and mid-buccal mucosa changes around single implants in the anterior maxilla. Reviewing three connection configurations: Platform switched conical (PS-conical); Platform switched parallel (PS-parallel); Platform matched parallel (PM-parallel).Entities:
Keywords: aesthetic region; bone level; implant-abutment connection; systematic review
Mesh:
Substances:
Year: 2021 PMID: 34418324 PMCID: PMC8638280 DOI: 10.1002/cre2.471
Source DB: PubMed Journal: Clin Exp Dent Res ISSN: 2057-4347
Search strings
| Pubmed (1673 hits) | |
| (“Dental Implants, Single‐Tooth” [Mesh] OR (implant*[tiab] AND (single[tiab] OR solitary[tiab]))) AND (“Maxilla” [Mesh] OR “Esthetics, Dental” [Mesh:NoExp] OR esthetic*[tiab] OR aesthetic*[tiab] OR anterior[tiab] OR maxilla*[tiab] OR incisor*[tiab] OR front*[tiab]) AND (“Alveolar Bone Loss” [Mesh] OR bone[tiab]) AND (“Clinical Trial” [Publication Type] OR “Cohort Studies” [Mesh] OR “Case Reports” [Publication Type] OR “Observational Study” [Publication Type] OR “Treatment Outcome” [Mesh:NoExp] OR “Comparative Study” [Publication Type] OR random*[tiab] OR trial[ti] OR outcome*[tiab] OR cohort[tiab] OR follow‐up[tiab] OR followup[tiab] OR prospectiv*[tiab] OR longitudinal*[tiab] OR case ser*[tiab]) | |
| Embase (1539 hits) | |
| (“single tooth implant”/exp OR (implant* AND (single OR solitary)):ab,ti) AND (“maxilla”/exp OR “esthetics”/exp OR (esthetic* OR aesthetic* OR anterior OR maxilla* OR incisor* OR front*):ab,ti) AND (“alveolar bone loss”/exp OR bone:ab,ti) AND (“clinical study”/exp OR “observational study”/exp OR “cohort analysis”/exp OR “comparative study”/exp OR “treatment outcome”/de OR trial:ti OR (random* OR outcome* OR cohort OR “follow‐up” OR followup OR prospectiv* OR longitudinal* OR “case ser*”):ab,ti) | |
| Cochrane (527 hits) | |
| (implant* AND (single OR solitary)) AND (esthetic* OR aesthetic* OR anterior OR maxilla* OR incisor* OR front*) AND (bone) | |
| Scopus (1626 hits) | |
| (TITLE‐ABS‐KEY (implant* AND ( single OR solitary))) AND (TITLE‐ABS‐KEY (dental OR tooth OR teeth OR crown*)) AND (TITLE‐ABS‐KEY (esthetic* OR aesthetic* OR anterior OR maxilla* OR incisor* OR front*)) AND (TITLE‐ABS‐KEY (bone)) AND (TITLE‐ABS‐KEY (“clinical trial*” OR prospectiv* OR cohort* OR “case report*” OR “case stud*” OR observational* OR “follow‐up” OR followup OR random* OR outcome* OR longitudinal* OR “case ser*” OR “clinical stud*” OR “controlled stud*”)) | |
| Open Grey (24 hits) | |
| Single implant | |
| African Journal | |
| Dental AND implant AND single AND maxilla AND bone | |
FIGURE 1Study identification and selection process. A total of 43 studies were included following the main screening process (up to July 1, 2020). The updated search resulted on December 1, 2020 resulted in one additional study
Characteristics and outcomes of the included studies
| Reference | Publication year | Follow‐up time (years) | Study type | Implant type | No of implants | Annual implant loss (%) | Annual bone level change in mm (mean ± | Annual mid‐buccal level change in mm. (mean ± | |
|---|---|---|---|---|---|---|---|---|---|
| PS‐conical | Kemppainen et al. ( | 1997 | 1 | RCT | Astra Tech ST | 35 | 2 | −0.14 ± 0.10 | nr |
| Palmer et al. ( | 2000 | 5 | Prosp. study | Astra Tech ST | 14 | 0 | 0.02 ± 0.10 | nr | |
| Cooper et al. ( | 2001 | 1 | Prosp. study | Astra Tech ST | 53 | 4 | −0.40 ± 0.51 | 0.34 ± 0.94 | |
| Norton ( | 2004 | 1 | Prosp. study | Astra Tech ST | 11 | 4 | −0.55 ± 0.49 | nr | |
| Cooper et al. ( | 2007 | 3 | Prosp. study | Astra Tech ST | 43 | 2 | −0.14 ± 0.32 | 0.17 ± 0.47 | |
| Gotfredsen ( | 2012 | 10 | Prosp. study | Astra Tech ST | 10 | 0 | −0.09 ± 0.04 | nr | |
| Vanlioglu et al. ( | 2012 | 5 | Prosp. study | Astra Tech OsseoSpeed | 10 | 0 | −0.05 ± 0.01 | nr | |
| Bashutski et al. ( | 2013 | 1 | RCT | Astra Tech OsseoSpeed | 24 | 8 | −0.53 ± 0.51 | nr | |
| Grandi et al. ( | 2013 | 1 | Prosp. study | JD Evolution | 24 | 4 | −0.60 ± 0.51 | nr | |
| Berberi et al. ( | 2014 | 5 | Prosp. study | Astra Tech OsseoSpeed | 20 | 0 | −0.04 ± 0.03 | nr | |
| Cooper et al. ( | 2014 | 5 | Prosp. study | Astra Tech OsseoSpeed | 49 | 0 | 0.02 ± 0.26 | 0.08 ± 0.21 | |
| Vanlioglu et al. ( | 2014 | 1 | Prosp. study | Straumann Bone Level implant | 55 | 0 | −0.10 ± 0.08 | nr | |
| Cosyn et al. ( | 2015 | 1 | Prosp. study | Nobel Active | 50 | 0 | −0.48 ± 0.46 | 0.06 ± 0.60 | |
| Esposito et al. ( | 2015 | 1 | RCT | Mega Gen, EZ Plus | 46 | 0 | −0.27 ± 0.14 | nr | |
| Raes et al. ( | 2015 | 2 | Prosp. study | Astra Tech OsseoSpeed | 85 | 2 | 0.02 ± 0.45 | 0.10 ± 0.45 | |
| Hsu et al. ( | 2016 | 1 | RCT | SuperLine Dentium | 13 | 0 | −0.21 ± 0.56 | −0.38 ± 0.49 | |
| Slagter et al. ( | 2016 | 1 | RCT | Nobel Active | 20 | 0 | −0.65 ± 0.46 | nr | |
| Yildiz et al. ( | 2016 | 1 | Prosp. study | Straumann Bone Level implant | 29 | 7 | 0.08 ± 0.82 | nr | |
| Allen et al. ( | 2017 | 2 | Prosp. study | Straumann Bone Level implant | 20 | 0 | −0.41 ± 0.26 | nr | |
| De Bruyckere et al. ( | 2018 | 1 | RCT | Nobel Active | 42 | 0 | −0.60 ± 0.69 | −0.18 ± 0.33 | |
| Eghbali et al. ( | 2018 | 5 | Prosp. study | Nobel Active | 32 | 0 | −0.09 ± 0.08 | −0.02 ± 0.07 | |
| Jonker et al. ( | 2018 | 1 | RCT | Straumann Bone Level implant | 43 | 2 | −0.42 ± 0.55 | nr | |
| Raes et al. ( | 2018 | 8 | Prosp. study | Astra Tech OsseoSpeed | 18 | 0 | −0.06 ± 0.24 | nr | |
| Zuiderveld et al. ( | 2018 | 1 | RCT | Nobel Replace CC | 40 | 0 | −0.02 ± 0.11 | −0.11 ± 1.19 | |
| Cooper et al. ( | 2019 | 3 | RCT | Astra Tech OsseoSpeed | 45 | 0 | −0.04 ± 0.17 | 0.07 ± 0.23 | |
| Friberg and Ahmadzai ( | 2019 | 1 | Prosp. study | Nobel Parallel CC | 22 | 2 | −0.41 ± 0.36 | nr | |
| Heydecke et al. ( | 2019 | 3 | Prosp. study | Nobel Replace CC | 90 | 0 | −0.29 ± 0.17 | nr | |
| Hosseini et al. ( | 2019 | 5 | Prosp. study | Astra Tech EV | 33 | 0 | −0.02 ± 0.07 | 0.07 ± 0.11 | |
| Meijndert et al. ( | 2019 | 5 | Prosp. study | Straumann Bone Level implant | 50 | 0 | −0.03 ± 0.13 | nr | |
| Zuiderveld et al. ( | 2019 | 1 | Prosp. study | Nobel Replace CC | 40 | 0 | 0.05 ± 0.44 | −0.04 ± 0.28 | |
| Wittneben et al. ( | 2020 | 3 | RCT | Straumann Bone Level implant | 39 | 0 | −0.10 ± 0.17 | nr | |
| PS‐parallel | Canullo et al. ( | 2013 | 2 | RCT | Sweden&Martina Premium SP | 20 | 0 | −0.17 ± 0.20 | nr |
| Canullo et al. ( | 2016 | 5 | RCT | Sweden&Martina Premium SP | 30 | 0 | −0.09 ± 0.07 | 0.08 ± 0.11 | |
| Canullo et al. ( | 2018 | 5 | Prosp. study | Sweden&Martina Premium SP | 22 | 0 | −0.06 ± 0.06 | nr | |
| Cooper et al. ( | 2019 | 3 | RCT | Biomet 3i, NanoTite Certain Prevail | 32 | 5 | −0.35 ± 0.17 | 0.10 ± 0.23 | |
| Lowy et al. ( | 2019 | 1 | RCT | BioHorizons Tapered Plus | 20 | 0 | −0.05 ± 0.21 | 0.10 ± 0.70 | |
| PM‐parallel | Raghoebar et al. ( | 2009 | 1 | RCT | Nobel Replace Groovy | 45 | 0 | −0.54 ± 0.13 | ‐0.63 ± 1.63 |
| Fu et al. ( | 2014 | 1 | RCT | Tapered Screw‐Vent | 26 | 0 | −1.28 ± 0.91 | nr | |
| Felice et al. ( | 2015 | 1 | RCT | Dentsply Friadent, XiVE S plus | 23 | 0 | −0.19 ± 0.10 | nr | |
| Meloni et al. ( | 2015 | 1 | RCT | Nobel Replace Tapered | 30 | 0 | −0.87 ± 0.19 | nr | |
| Den Hartog et al. ( | 2016 | 5 | RCT | Nobel Replace Tapered Groovy | 27 | 1 | −0.03 ± 0.10 | nr | |
| Guarnieri et al. ( | 2016 | 3 | Prosp. study | BioHorizons Tapered Internal | 13 | 0 | −0.14 ± 0.07 | −0.01 ± 0.04 | |
| Hsu et al. ( | 2016 | 1 | RCT | Zimmer dental, Tapered Screw‐Vent | 13 | 0 | −0.74 ± 0.47 | nr | |
| Den Hartog et al. ( | 2017 | 5 | RCT | Nobel Tapered Groovy | 54 | 0 | −0.25 ± 0.20 | nr | |
| Gjelvold et al. ( | 2017 | 1 | RCT | BioHorizons Tapered Internal | 50 | 2 | −0.63 ± 0.54 | 0.21 ± 0.46 | |
| Cooper et al. ( | 2019 | 3 | RCT | Nobel Speedy Replace | 34 | 5 | −0.34 ± 0.17 | nr | |
| Lowy et al. ( | 2019 | 1 | RCT | BioHorizons Internal | 20 | 0 | −0.65 ± 0.59 | 0.50 ± 0.90 | |
| Gjelvold et al. ( | 2020 | 1 | Prosp. study | BioHorizons Tapered Internal | 21 | 2 | −0.4 ± 0.41 | −0.02 ± 0.36 |
FIGURE 2Forest plots for random effects meta‐analysis of studies evaluating bone level change in the PS‐conical group
FIGURE 3Forest plots for random effects meta‐analysis of studies evaluating of bone level change in the PS‐parallel group
FIGURE 4Forest plots for random effects meta‐analysis of studies evaluating of bone level change in the PM‐parallel group